COMMUNIQUÉS West-GlobeNewswire

Atara Biotherapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 8, 2019
01/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Anne Myong Joins Align Technology Board of Directors
01/08/2019
SAN JOSE, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today that it has appointed Anne Myong to its board of directors. Ms. Myong was previously Senior Vice President and [...]
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
01/08/2019
SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare [...]
Arcturus Therapeutics Receives up to $15 Million Commitment from the Cystic Fibrosis Foundation to Create mRNA Therapies to Treat Cystic Fibrosis Patients
01/08/2019
SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company, today announced that the Cystic Fibrosis Foundation (CF Foundation), has increased its [...]
Déclaration d'actions et de droits de vote de la société Valneva SE - Juillet 2019
01/08/2019
VALNEVA Déclaration d’actions et de droits de vote – JUILLET 2019 Dénomination sociale : VALNEVA Adresse du siège social : 6 rue Alain Bombard, 44800 Saint-Herblain Marché réglementé Euronext Paris de NYSE Euronext - [...]
Number of voting rights as of July 31, 2019
01/08/2019
Nicox SA Société anonyme with a registered capital of € 29,910,120 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On August 1, 2019, MONTHLY PUBLICATION OF THE [...]
Nombre de droits de vote au 31 juillet 2019
01/08/2019
Nicox SA Société anonyme au capital de 29 910 120 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 er août 2019, PUBLICATION MENSUELLE DU NOMBRE D’ [...]
Teligent, Inc. to Hold Conference Call for Second Quarter 2019 Results on Monday August 5th, 2019
01/08/2019
BUENA, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday August 5 [...]
AroCell enters a collaboration with Dana Farber Cancer Institute
01/08/2019
Today AroCell announces a collaboration with Dana Faber Cancer Institute to evaluate AroCell’s TK 210 ELISA assay on CDK4/6 inhibitor treated patients. The aim of the study is to examine concordance of TK 1 [...]
Valneva rapport semestriel 2019
01/08/2019
2019_08_01_Valneva Half-Year Report_FR_FINAL Pièce jointe 2019_08_01_Valneva Half-Year Report_FR_FINAL
Zealand Pharma hosts conference call on August 15 at 4 pm CET (10 am EST) to present first half results for 2019
01/08/2019
Press Release – No. 17 / 2019 Copenhagen, August 1, 2019 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR no. 20 04 50 78) announces that it will host a conference call on August 15, 2019 at 4 pm CET/10 am EST [...]
Syneos Health CEO Alistair Macdonald Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine
01/08/2019
MORRISVILLE, N.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that CEO Alistair Macdonald has been named to [...]
Rafael Pharmaceuticals Announces Expansion into Austria, South Korea and Spain of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
01/08/2019
Cranbury, NJ, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Announces Expansion into Austria, South Korea and Spain of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 ® (devimistat) in Patients with Relapsed [...]
Philips completes acquisition of Carestream Health’s Healthcare Information Systems business in majority of relevant countries
01/08/2019
August 1, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has completed the previously announced acquisition of Carestream Health Inc [...]
The Alliance for Regenerative Medicine Releases Q2 2019 Global Sector Report, Highlighting Industry Trends and Metrics
01/08/2019
WASHINGTON, D.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly global sector report, offering an in-depth look at cell [...]
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019
01/08/2019
Gaithersburg, Md., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report [...]
Generex Biotechnology Welcomes MediSource Partners to the NuGenerex Family of Companies
01/08/2019
MediSource Partners Fresh Approach to Healthcare Network of healthcare providers, facilities, suppliers, and distributors Value Analysis Consulting Group Purchasing Distributorship (GPD) https://medisourcepartners.com [...]
INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit
01/08/2019
LA JOLLA, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Seelos Therapeutics Reports Q2 2019 Pipeline Update
01/08/2019
NEW YORK, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, today released its second quarter pipeline update. “We have made tremendous progress on [...]

Pages